Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Homeoptic is a homeopathic eye drop formulation indicated for the relief of irritation and ocular discomfort caused by external factors such as dust, wind, smoke, or visual fatigue. It is suitable for use by adults and children, including contact lens wearers. The product contains highly diluted active substances commonly used in homeopathy—such as Euphrasia officinalis (eyebright), Calendula officinalis (marigold), Magnesia carbonica, Chamomilla vulgaris (chamomile), Belladonna, Mercurius solubilis (mercury), and Hepar sulfuris calcareum—dissolved in a sterile saline solution. The mechanism of action follows the principles of homeopathy rather than conventional pharmacology; it is based on the idea that highly diluted substances can stimulate the body's self-healing processes[1][2][3][4]. Homeoptic does not have an established mechanism of action recognized by conventional medicine.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on homeoptic.